Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus

Blood Pressure Monitoring
Kazuo EguchiKazuomi Kario

Abstract

Cardiovascular prognosis in diabetic white-coat hypertension (WCH) has not yet been described. We designed this study to investigate the impact of WCH on cardiovascular events in patients with type 2 diabetes, compared with those having type 2 diabetes along with sustained hypertension (SH), and with nondiabetic hypertensive individuals. We performed ambulatory blood pressure (BP) monitoring in 1207 consecutive hypertensive patients at baseline, and they were followed up for 49+/-22 months. The mean age was 70.7+/-9.8 years; 262 had type 2 diabetes; and 945 did not. They were classified as having SH with diabetes (n=210); diabetic WCH (n=52); SH alone (n=719); or WCH alone (n=226), using awake BP of 135/85 mmHg as the cutoff value. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals of the risk for cardiovascular events, after controlling for age, sex, body mass index, current smoking, serum creatinine, and clinical systolic BP. During the follow-up period, 97 cardiovascular events occurred. The incidence of cardiovascular events in the diabetic SH group was significantly higher than in the diabetic WCH, nondiabetic SH, and nondiabetic WCH (P<0.05; log-rank test) groups. In Cox regressio...Continue Reading

References

Jul 14, 2001·Journal of the American College of Cardiology·K KarioT G Pickering
Jun 11, 2002·Blood Pressure Monitoring·J A StaessenUNKNOWN Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring
Jun 13, 2003·The New England Journal of Medicine·Denis L ClementUNKNOWN Office versus Ambulatory Pressure Study Investigators
Sep 23, 2003·Stroke; a Journal of Cerebral Circulation·Kazuo EguchiKazuyuki Shimada
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 25, 2003·Diabetes Care·UNKNOWN American Diabetes Association
Dec 25, 2003·Diabetes Care·Carlos Arauz-PachecoUNKNOWN American Diabetes Association
Sep 29, 2004·Archives of Internal Medicine·James R Sowers
Dec 15, 2004·Hypertension·Paolo VerdecchiaKazuomi Kario
Jan 18, 2006·Blood Pressure Monitoring·Vasilios KotsisNikos Zakopoulos
Apr 20, 2006·Diabetes Research and Clinical Practice·Lilliam FloresEnric Esmatjes

❮ Previous
Next ❯

Citations

Jun 11, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Gil F SallesClaudia R L Cardoso
Aug 13, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Manuel GorostidiUNKNOWN Spanish Society of Hypertension ABPM Registry investigators
Aug 13, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuo Eguchi
Jun 2, 2011·International Journal of Hypertension·Kazuo Eguchi
Jun 8, 2013·Acta Diabetologica·Claudia R L CardosoGil F Salles
Nov 13, 2009·Diabetes Care·Gianfranco Parati, Grzegorz Bilo
Nov 13, 2009·Diabetes Care·Giuseppe ManciaGuido Grassi
Nov 13, 2009·Diabetes Care·Michael Bursztyn, Iddo Z Ben-Dov
Sep 24, 2014·Hypertension·Giuseppe ManciaAlberto Zanchetti
Jan 15, 2010·Blood Pressure Monitoring·Sante D Pierdomenico, Franco Cuccurullo
May 7, 2019·Annals of Internal Medicine·James Brian Byrd, Robert D Brook

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.